Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Pediatrics. 2014 Jun;133(Suppl 3):S85–S90. doi: 10.1542/peds.2014-0122B

Table 1.

Workgroup Members

Karen Albritton Cook Children’s Medical Center Fort Worth TX
Ronald Barr McMaster University Hamilton ON
Lynda Kwon Beaupin Roswell Park Cancer Institute, Buffalo NY
Archie Bleyer Oregon Health Science University St. Charles Regional Cancer Center Bend OR
Rebecca Block Oregon Health Science University Portland OR
Peter Coccia University of Nebraska Medical Center Omaha NE
Deborah Vollmer Dhalke Texas A&M, Seton Family of Healthcare, College Station, TX
Judy Felgenhauer Providence Sacred Heart Medical Center & Children’s Hospital, Spokane WA
Steven Friedman National Cancer Institute - Cancer Therapy Evaluation Program, Bethesda MD
Abha Gupta Hospital for Sick Children, Toronto ON
Brandon Hayes-Lattin Oregon Health Science University, Portland OR
Casey Flooke Children’s Hospitals and Clinics of Minnesota, Minneapolis MN
Daniel Indelicato University of Florida, Jacksonville, FL
Rebecca Johnson Seattle Children’s Hospital, Seattle WA
Susan Lindemulder Oregon Health Science University, Portland OR
Margo Michaels Education Network to Advance Clinical Trials (ENACCT), Bethesda
MD
Nita Seibel National Cancer Institute - Cancer Therapy Evaluation Program, Bethesda MD
Leonard Sender Children’s Hospital of Orange County, Orange CA
Peter Shaw Children’s Hospital of Pittsburgh, Pittsburgh PA
Ashley Wilder Smith National Cancer Institute, Bethesda MD
HHS Vulnerability Disclosure